ZC3H3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-03341
![Western Blot: ZC3H3 Antibody [NBP1-03341]](https://resources.bio-techne.com/images/products/ZC3H3-Antibody-Western-Blot-NBP1-03341-img0002.jpg "Western Blot: ZC3H3 Antibody [NBP1-03341]")
Key Product Details
Validated by
Independent Antibodies, Biological Validation
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.2 mg/ml
Product Summary for ZC3H3 Antibody
Immunogen
The immunogen recognized by this antibody maps to a region between residue 898 and 948 of human zinc finger CCCH-type containing 3 using the numbering given in entry NP_055932.2 (GeneID 23144).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for ZC3H3 Antibody
Applications for ZC3H3 Antibody
Application
Recommended Usage
Immunoprecipitation
2-5 ug/mg lysate
Western Blot
1:2,000 - 1:10,000
Application Notes
Western blot of lysates performed using standard western blot reagents and 4-8% SDS-PAGE.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
TBS and 0.1% BSA
Preservative
0.09% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: ZC3H3
Alternate Names
KIAA0150zinc finger CCCH-type domain containing 3, ZC3HDC3, zinc finger CCCH domain-containing protein 3, zinc finger CCCH type domain containing 3, zinc finger CCCH-type containing 3
Entrez Gene IDs
23144 (Human)
Gene Symbol
ZC3H3
UniProt
Additional ZC3H3 Products
Product Documents for ZC3H3 Antibody
Product Specific Notices for ZC3H3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...